| 100490-24-2 |
|
1,8-Naphthyridine-3-carboxylic acid,1-(3,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- |
C19H15F3N4O3 |
- |
-
|
| 100490-28-6 |
|
1-(4-Chloro-Phenyl)-6-Fluoro-4-Oxo-7-Piperazin-1-Yl-1,4-Dihydro-[1,8]Naphthyridine-3-Carboxylic Acid |
C19H16ClFN4O3 |
- |
-
|
| 100490-36-6 |
对甲苯磺酸妥舒沙星 |
Tosufloxacin tosilate |
C19H15F3N4O3S.C7H8O3S |
576.5400 |
-
|
| 100490-64-0 |
|
1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo- |
C20H18F2N4O3 |
- |
-
|
| 100490-65-1 |
|
1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- |
C20H18F2N4O3 |
- |
-
|
| 100490-71-9 |
|
1,8-Naphthyridine-3-carboxylic acid,1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo- |
C20H17F3N4O3 |
- |
-
|
| 100490-72-0 |
|
1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
C20H17F3N4O3 |
418.3700 |
-
|
| 100490-80-0 |
|
1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(3-hydroxy-1-pyrrolidinyl)-4-oxo- |
C19H15F2N3O4 |
- |
-
|
| 100490-94-6 |
|
Tosuflo |
C26H23F3N4O6S |
576.5500 |
-
|
| 100490-99-1 |
2-(2,6-二氯-5-氟吡啶-3-羰基)-3-(2,4-二氟苯基氨基)丙烯酸乙酯 |
Ethyl 2-(2,6-dichloro-5-fluoropyridin-3-carbonyl)-3-(2,4-difluorphenylamino)acrylate |
C17H11Cl2F3N2O3 |
419.1800 |
-
|
| 100491-29-0 |
1-(2,4-二氟苯基)-7-氯-6-氟-4-氧代吡啶并[2,3-B]吡啶-3-羧酸乙酯 |
Ethyl1-(2,4-Difluorophenyl)-7-Chloro-6-Fluoro-4-Oxohydropyridino[2,3-B]Pyridine-3-C |
C17H10ClF3N2O3 |
382.7200 |
-
|
| 100491-31-4 |
|
1,8-Naphthyridine-3-carboxylic acid,7-chloro-6-fluoro-1-(3-fluorophenyl)-1,4-dihydro-4-oxo-, ethyl ester |
C17H11ClF2N2O3 |
- |
-
|
| 100491-32-5 |
|
1,8-Naphthyridine-3-carboxylic acid,7-chloro-6-fluoro-1-(2-fluorophenyl)-1,4-dihydro-4-oxo-, ethyl ester |
C17H11ClF2N2O3 |
- |
-
|
| 100491-33-6 |
|
1,8-Naphthyridine-3-carboxylic acid,7-chloro-1-(3,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester |
C17H10ClF3N2O3 |
- |
-
|
| 100491-37-0 |
|
1,8-Naphthyridine-3-carboxylic acid,7-chloro-1-(4-chlorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, ethyl ester |
C17H11Cl2FN2O3 |
- |
-
|
| 100491-52-9 |
|
1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-, ethyl ester |
C22H22F2N4O3 |
- |
-
|
| 100491-63-2 |
|
1,8-Naphthyridine-3-carboxylic acid,1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, ethyl ester |
C22H21F3N4O3 |
- |
-
|
| 100491-97-2 |
|
1,8-Naphthyridine-3-carboxylic acid,7-[3-(acetylamino)-1-pyrrolidinyl]-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-, ethyl ester |
C23H22F2N4O4 |
- |
-
|
| 100492-04-4 |
|
1-(2,4-DIFLUOROPHENYL)-6-1LUORO-7-CHLONDE-4-OXO-1,4-DIHYDRO-1,8-NAPTHYRIDINE-3-CARBOXYLIC ACID[TOSUFLOXACIN PHARMACEUTICAL INTERMEDIATE] |
C15H6ClF3N2O3 |
- |
-
|
| 100492-07-7 |
|
1,8-Naphthyridine-3-carboxylic acid,1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-, ethyl ester |
C22H21F3N4O3 |
- |
-
|